论文信息 - Myelodysplastic syndromes standardized response criteria: further definition.

Myelodysplastic syndromes standardized response criteria: further definition.

We read with interest Dr Raza's letter[1][1] in response to the International Working Group's (IWG's) proposal to provide standardized response criteria in myelodysplastic syndromes (MDSs).[2][2] Developing consistent guidelines for MDSs presents a challenge since the clinical course of the disease

[1] A. Raza. Improve or abandon the standardized response criteria for myelodysplastic syndromes recommended by the International Working Group. , 2001, Blood.

[2] B. Cheson,et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. , 2000, Blood.

[3] J. Armitage,et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] I. Dybedal,et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. , 1998, Blood.

[5] A. List,et al. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome. , 1997, Blood.

[6] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[7] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[8] P. Greenberg,et al. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. , 1996, Blood.